Health Canada drug identification number

DIN 00664227 — DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML 4 MG

DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML is a solution of Dexamethasone Sodium Phosphate marketed by SANDOZ CANADA INCORPORATED. The full Dexamethasone Sodium Phosphate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
00664227
Brand name
DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML
Strength
4 MG
Dosage form
SOLUTION
Route
INTRAMUSCULAR; INTRASYNOVIAL; INTRAVENOUS
Manufacturer
SANDOZ CANADA INCORPORATED
Health Canada status
MARKETED
Drug class
Water-soluble synthetic glucocorticoid corticosteroid (phosphate ester salt of dexamethasone)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Dexamethasone Sodium Phosphate products

DINBrandStrengthFormManufacturerStatus
02023865 DEXAMETHASONE 0.1 % SOLUTION PHARMA STULLN INC. MARKETED
02387743 DEXAMETHASONE OMEGA UNIDOSE 10 MG SOLUTION OMEGA LABORATORIES LIMITED MARKETED
01977547 DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP 4 MG SOLUTION STERIMAX INC MARKETED
00627763 ODAN-DEXAMETHASONE 0.1 % SOLUTION ODAN LABORATORIESLTD DORMANT
00751863 PMS-DEXAMETHASONE SOD PHOSPHATE INJ 4MG/ML 4 MG SOLUTION PHARMASCIENCE INC DORMANT

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.